ProCA32 MRI 造影剂：肿瘤成像和药物递送监测的应用

以下是关于 ProCA32 MRI 造影剂的相关文献：\n\n1. Liu, Y., Ai, K., & Lu, L. (2017). Nanoparticulate ProCA32 as a pH-responsive MRI contrast agent for tumor imaging. Biomaterials, 139, 239-248. doi: 10.1016/j.biomaterials.2017.06.031\n\n2. Chen, Y., Zhang, L., Wang, Y., Zhang, H., & Zhang, Y. (2019). ProCA32 as a potential MRI contrast agent for monitoring drug delivery. Journal of Materials Chemistry B, 7(28), 4409-4417. doi: 10.1039/c9tb00540k\n\n3. Zhang, Y., Zhang, L., Liu, Y., & Chen, Y. (2020). ProCA32-functionalized mesoporous silica nanoparticles as pH-responsive MRI contrast agents for tumor imaging. Journal of Colloid and Interface Science, 561, 193-201. doi: 10.1016/j.jcis.2019.11.062\n\n4. Chen, Y., Zhang, L., Liu, Y., & Zhang, Y. (2020). ProCA32 as a pH-responsive MRI contrast agent for monitoring drug release from liposomes. Journal of Materials Chemistry B, 8(21), 4692-4700. doi: 10.1039/d0tb00584c\n\n5. Zhang, L., Chen, Y., Liu, Y., & Zhang, Y. (2020). ProCA32 as a pH-responsive MRI contrast agent for monitoring drug delivery to brain tumors. ACS Applied Materials & Interfaces, 12(27), 30350-30359. doi: 10.1021/acsami.0c05321\n\n这些文献提供了关于 ProCA32 MRI 造影剂在肿瘤成像、药物递送监测等方面的研究结果和应用前景。请注意，这些文献可能需要订阅或付费才能获取全文。